114 related articles for article (PubMed ID: 11711635)
21. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
Porotto M; Fornabaio M; Kellogg GE; Moscona A
J Virol; 2007 Apr; 81(7):3216-28. PubMed ID: 17229690
[TBL] [Abstract][Full Text] [Related]
22. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion.
Moscona A; Peluso RW
J Virol; 1991 Jun; 65(6):2773-7. PubMed ID: 1851852
[TBL] [Abstract][Full Text] [Related]
23. The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.
Blick TJ; Sahasrabudhe A; McDonald M; Owens IJ; Morley PJ; Fenton RJ; McKimm-Breschkin JL
Virology; 1998 Jun; 246(1):95-103. PubMed ID: 9656997
[TBL] [Abstract][Full Text] [Related]
24. Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.
Palermo LM; Porotto M; Yokoyama CC; Palmer SG; Mungall BA; Greengard O; Niewiesk S; Moscona A
J Virol; 2009 Jul; 83(13):6900-8. PubMed ID: 19386708
[TBL] [Abstract][Full Text] [Related]
25. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.
Skiadopoulos MH; Surman SR; Durbin AP; Collins PL; Murphy BR
Virology; 2000 Jun; 272(1):225-34. PubMed ID: 10873765
[TBL] [Abstract][Full Text] [Related]
26. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II.
Palermo LM; Porotto M; Greengard O; Moscona A
J Virol; 2007 Sep; 81(17):9152-61. PubMed ID: 17567695
[TBL] [Abstract][Full Text] [Related]
27. In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir.
Barnett JM; Cadman A; Burrell FM; Madar SH; Lewis AP; Tisdale M; Bethell R
Virology; 1999 Dec; 265(2):286-95. PubMed ID: 10600600
[TBL] [Abstract][Full Text] [Related]
28. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
Zürcher T; Yates PJ; Daly J; Sahasrabudhe A; Walters M; Dash L; Tisdale M; McKimm-Breschkin JL
J Antimicrob Chemother; 2006 Oct; 58(4):723-32. PubMed ID: 16891631
[TBL] [Abstract][Full Text] [Related]
29. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.
Palmer SG; DeVito I; Jenkins SG; Niewiesk S; Porotto M; Moscona A
J Virol; 2014 Nov; 88(22):13495-502. PubMed ID: 25210187
[TBL] [Abstract][Full Text] [Related]
30. Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein.
Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang Z
Virus Res; 2013 Jun; 174(1-2):137-47. PubMed ID: 23562646
[TBL] [Abstract][Full Text] [Related]
31. Amino acid substitutions in leucine zipper motif in the F-specific domain of human parainfluenza virus 3 HN protein play important roles in the protein function.
Zhang W; Ren G; Wu B; Liu X; Wang G; Song Y; Xu H; Wen H; Wang Z
Intervirology; 2008; 51(5):311-21. PubMed ID: 19018146
[TBL] [Abstract][Full Text] [Related]
32. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
[TBL] [Abstract][Full Text] [Related]
33. Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN).
Streltsov VA; Pilling P; Barrett S; McKimm-Breschkin JL
Antiviral Res; 2015 Nov; 123():216-23. PubMed ID: 26364554
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.
Staschke KA; Colacino JM; Baxter AJ; Air GM; Bansal A; Hornback WJ; Munroe JE; Laver WG
Virology; 1995 Dec; 214(2):642-6. PubMed ID: 8553569
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro.
Baigent SJ; Bethell RC; McCauley JW
Virology; 1999 Oct; 263(2):323-38. PubMed ID: 10544106
[TBL] [Abstract][Full Text] [Related]
36. Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.
Suzuki T; Takahashi T; Guo CT; Hidari KI; Miyamoto D; Goto H; Kawaoka Y; Suzuki Y
J Virol; 2005 Sep; 79(18):11705-15. PubMed ID: 16140748
[TBL] [Abstract][Full Text] [Related]
37. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
Gubareva LV; Webster RG; Hayden FG
Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
[TBL] [Abstract][Full Text] [Related]
39. Identification of amino acid positions associated with neuraminidase activity of the hemagglutinin-neuraminidase glycoprotein of Sendai virus.
Gorman WL; Takahashi T; Scroggs RA; Portner A
Virology; 1991 Feb; 180(2):803-8. PubMed ID: 1846501
[TBL] [Abstract][Full Text] [Related]
40. Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match.
Kaverin NV; Gambaryan AS; Bovin NV; Rudneva IA; Shilov AA; Khodova OM; Varich NL; Sinitsin BV; Makarova NV; Kropotkina EA
Virology; 1998 May; 244(2):315-21. PubMed ID: 9601502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
